AAAAAA

   
Results: 1-18 |
Results: 18
PRODRUG AND ANALOG APPROACHES TO IMPROVING THE INTESTINAL-ABSORPTION OF A CYCLIC PEPTIDE, GPIIB IIIA RECEPTOR ANTAGONIST/
Authors: SAITOH H AUNGST BJ
Citation: H. Saitoh et Bj. Aungst, PRODRUG AND ANALOG APPROACHES TO IMPROVING THE INTESTINAL-ABSORPTION OF A CYCLIC PEPTIDE, GPIIB IIIA RECEPTOR ANTAGONIST/, Pharmaceutical research, 14(8), 1997, pp. 1026-1029
RESTRICTED INTESTINAL-ABSORPTION OF SOME BETA-LACTAM ANTIBIOTICS BY AN ENERGY-DEPENDENT EFFLUX SYSTEM IN RAT INTESTINE
Authors: SAITOH H FUJISAKI H AUNGST BJ MIYAZAKI K
Citation: H. Saitoh et al., RESTRICTED INTESTINAL-ABSORPTION OF SOME BETA-LACTAM ANTIBIOTICS BY AN ENERGY-DEPENDENT EFFLUX SYSTEM IN RAT INTESTINE, Pharmaceutical research, 14(5), 1997, pp. 645-649
AMPHIPHILIC VEHICLES IMPROVE THE ORAL BIOAVAILABILITY OF A POORLY SOLUBLE HIV PROTEASE INHIBITOR AT HIGH-DOSES
Authors: AUNGST BJ NGUYEN NH ROGERS NJ ROWE SM HUSSAIN MA WHITE SJ SHUM L
Citation: Bj. Aungst et al., AMPHIPHILIC VEHICLES IMPROVE THE ORAL BIOAVAILABILITY OF A POORLY SOLUBLE HIV PROTEASE INHIBITOR AT HIGH-DOSES, International journal of pharmaceutics, 156(1), 1997, pp. 79-88
INTRANASAL ABSORPTION OF OXYMORPHONE
Authors: HUSSAIN MA AUNGST BJ
Citation: Ma. Hussain et Bj. Aungst, INTRANASAL ABSORPTION OF OXYMORPHONE, Journal of pharmaceutical sciences, 86(8), 1997, pp. 975-976
INTRANASAL ABSORPTION OF THE PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR ANTAGONIST, DMP-755, AND THE EFFECT OF ANESTHESIA ON NASAL BIOAVAILABILITY/
Authors: HUSSAIN MA AUNGST BJ KAPIL R MOUSA SA
Citation: Ma. Hussain et al., INTRANASAL ABSORPTION OF THE PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR ANTAGONIST, DMP-755, AND THE EFFECT OF ANESTHESIA ON NASAL BIOAVAILABILITY/, Journal of pharmaceutical sciences, 86(12), 1997, pp. 1358-1360
SYNTHESIS OF WATER-SOLUBLE PRODRUG OF DMP323
Authors: JADHAV PK WOERNER FJ AUNGST BJ
Citation: Pk. Jadhav et al., SYNTHESIS OF WATER-SOLUBLE PRODRUG OF DMP323, Bioorganic & medicinal chemistry letters, 6(19), 1996, pp. 2259-2262
EFFECTS OF STRUCTURAL MODIFICATIONS ON THE INTESTINAL PERMEABILITY OFANGIOTENSIN-II RECEPTOR ANTAGONISTS AND THE CORRELATION OF IN-VITRO, IN-SITU, AND IN-VIVO ABSORPTION
Authors: RIBADENEIRA MD AUNGST BJ EYERMANN CJ HUANG SM
Citation: Md. Ribadeneira et al., EFFECTS OF STRUCTURAL MODIFICATIONS ON THE INTESTINAL PERMEABILITY OFANGIOTENSIN-II RECEPTOR ANTAGONISTS AND THE CORRELATION OF IN-VITRO, IN-SITU, AND IN-VIVO ABSORPTION, Pharmaceutical research, 13(2), 1996, pp. 227-233
INTESTINAL-ABSORPTION BARRIERS AND TRANSPORT MECHANISMS, INCLUDING SECRETORY TRANSPORT, FOR A CYCLIC PEPTIDE, FIBRINOGEN ANTAGONIST
Authors: AUNGST BJ SAITOH H
Citation: Bj. Aungst et H. Saitoh, INTESTINAL-ABSORPTION BARRIERS AND TRANSPORT MECHANISMS, INCLUDING SECRETORY TRANSPORT, FOR A CYCLIC PEPTIDE, FIBRINOGEN ANTAGONIST, Pharmaceutical research, 13(1), 1996, pp. 114-119
ENHANCEMENT OF THE INTESTINAL-ABSORPTION OF PEPTIDES AND NONPEPTIDES
Authors: AUNGST BJ SAITOH H BURCHAM DL HUANG SM MOUSA SA HUSSAIN MA
Citation: Bj. Aungst et al., ENHANCEMENT OF THE INTESTINAL-ABSORPTION OF PEPTIDES AND NONPEPTIDES, Journal of controlled release, 41(1-2), 1996, pp. 19-31
THE SECRETORY INTESTINAL TRANSPORT OF SOME BETA-LACTAM ANTIBIOTICS AND ANIONIC COMPOUNDS - A MECHANISM CONTRIBUTING TO POOR ORAL ABSORPTION
Authors: SAITOH H GERARD C AUNGST BJ
Citation: H. Saitoh et al., THE SECRETORY INTESTINAL TRANSPORT OF SOME BETA-LACTAM ANTIBIOTICS AND ANIONIC COMPOUNDS - A MECHANISM CONTRIBUTING TO POOR ORAL ABSORPTION, The Journal of pharmacology and experimental therapeutics, 278(1), 1996, pp. 205-211
POSSIBLE INVOLVEMENT OF MULTIPLE P-GLYCOPROTEIN-MEDIATED EFFLUX SYSTEMS IN THE TRANSPORT OF VERAPAMIL AND OTHER ORGANIC CATIONS ACROSS RAT INTESTINE
Authors: SAITOH H AUNGST BJ
Citation: H. Saitoh et Bj. Aungst, POSSIBLE INVOLVEMENT OF MULTIPLE P-GLYCOPROTEIN-MEDIATED EFFLUX SYSTEMS IN THE TRANSPORT OF VERAPAMIL AND OTHER ORGANIC CATIONS ACROSS RAT INTESTINE, Pharmaceutical research, 12(9), 1995, pp. 1304-1310
PRODRUGS TO IMPROVE THE ORAL BIOAVAILABILITY OF A DIACIDIC NONPEPTIDEANGIOTENSIN-II ANTAGONIST
Authors: AUNGST BJ BLAKE JA ROGERS NJ SAITOH H HUSSAIN MA ENSINGER CL PRUITT JR
Citation: Bj. Aungst et al., PRODRUGS TO IMPROVE THE ORAL BIOAVAILABILITY OF A DIACIDIC NONPEPTIDEANGIOTENSIN-II ANTAGONIST, Pharmaceutical research, 12(5), 1995, pp. 763-767
METABOLISM OF A NEUROTENSIN(8-13) ANALOG BY INTESTINAL AND NASAL ENZYMES, AND APPROACHES TO STABILIZE THIS PEPTIDE AT THESE ABSORPTION SITES
Authors: AUNGST BJ PHANG S
Citation: Bj. Aungst et S. Phang, METABOLISM OF A NEUROTENSIN(8-13) ANALOG BY INTESTINAL AND NASAL ENZYMES, AND APPROACHES TO STABILIZE THIS PEPTIDE AT THESE ABSORPTION SITES, International journal of pharmaceutics, 117(1), 1995, pp. 95-100
NASAL MUCOSAL METABOLISM AND ABSORPTION OF PENTAPEPTIDE ENKEPHALIN ANALOGS HAVING VARYING N-TERMINAL AMINO-ACIDS
Authors: HUSSAIN MA SEETHARAM R WILK RR AUNGST BJ KETTNER CA
Citation: Ma. Hussain et al., NASAL MUCOSAL METABOLISM AND ABSORPTION OF PENTAPEPTIDE ENKEPHALIN ANALOGS HAVING VARYING N-TERMINAL AMINO-ACIDS, Journal of pharmaceutical sciences, 84(1), 1995, pp. 62-64
NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS - THE DISCOVERY OF DMP-581 AND DMP-811
Authors: CARINI DJ ARDECKY RJ ENSINGER CL PRUITT JR WEXLER RR WONG PC HUANG SM AUNGST BJ TIMMERMANS PBMWM
Citation: Dj. Carini et al., NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS - THE DISCOVERY OF DMP-581 AND DMP-811, Bioorganic & medicinal chemistry letters, 4(1), 1994, pp. 63-68
SITE-DEPENDENCE AND STRUCTURE-EFFECT RELATIONSHIPS FOR ALKYLGLYCOSIDES AS TRANSMUCOSAL ABSORPTION PROMOTERS FOR INSULIN
Authors: AUNGST BJ
Citation: Bj. Aungst, SITE-DEPENDENCE AND STRUCTURE-EFFECT RELATIONSHIPS FOR ALKYLGLYCOSIDES AS TRANSMUCOSAL ABSORPTION PROMOTERS FOR INSULIN, International journal of pharmaceutics, 105(3), 1994, pp. 219-225
NASAL MUCOSAL METABOLISM OF AN LH-RH FRAGMENT AND INHIBITION WITH BOROLEUCINE
Authors: HUSSAIN MA AUNGST BJ
Citation: Ma. Hussain et Bj. Aungst, NASAL MUCOSAL METABOLISM OF AN LH-RH FRAGMENT AND INHIBITION WITH BOROLEUCINE, International journal of pharmaceutics, 105(1), 1994, pp. 7-10
NOVEL FORMULATION STRATEGIES FOR IMPROVING ORAL BIOAVAILABILITY OF DRUGS WITH POOR MEMBRANE PERMEATION OR PRESYSTEMIC METABOLISM
Authors: AUNGST BJ
Citation: Bj. Aungst, NOVEL FORMULATION STRATEGIES FOR IMPROVING ORAL BIOAVAILABILITY OF DRUGS WITH POOR MEMBRANE PERMEATION OR PRESYSTEMIC METABOLISM, Journal of pharmaceutical sciences, 82(10), 1993, pp. 979-987
Risultati: 1-18 |